FDA Approves Mirdametinib: Is this the Breakthrough NF1-PN Patients Have Been Waiting For? Other 3 Mins Read FDA Approves Mirdametinib for NF1-PN: A New Option for PatientsIntroduction: The FDA has recently approved Mirdametinib (Gomekli) from SpringWorks Therapeutics…
